Programmed death 1 inhibitor combined with radiotherapy decreases epidermal growth factor receptor expression in breast cancer

Authors

Institutions

Publication Details

Journal
Hereditas
Published
2025-08-16
DOI
https://doi.org/10.1186/s41065-025-00472-x
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Programmed death 1 inhibitor combined with radiotherapy decreases epidermal growth factor receptor expression in breast cancer

You Wu
1 citations
Hereditas
Cancer Immunotherapy and Biomarkers
1.05
article

Programmed death 1 inhibitor combined with radiotherapy decreases epidermal growth factor receptor expression in breast cancer

You Wu
article en
1 citations

Abstract

No abstract available for this paper.
HereditasVol. 162(1)
Nanjing University of Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 19%
Cancer Immunotherapy and Biomarkers
1.05
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Programmed death 1 inhibitor combined with radiotherapy decreases epidermal growth factor receptor expression in breast cancer — You Wu · Hereditas (2025) | TGRS Research Map | TGRS